PLEK2 and cancer: Interestingly, while PLEK2 emerged as a risk factor contributing to poorer outcomes in a vast array of cancers, it simultaneously served as a protective factor in specific cancer types, including BLCA, BRCA, COAD, KIRC, KIRP, LAML, PCPG, READ, THCA, and USC.